Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - Other
Ratios

Immucell (ICCC) Leases (2020 - 2025)

Immucell (ICCC) has disclosed Leases for 6 consecutive years, with $4.4 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Leases fell 3.77% year-over-year to $4.4 million, compared with a TTM value of $4.4 million through Sep 2025, down 3.77%, and an annual FY2024 reading of $4.6 million, changed 0.23% over the prior year.
  • Leases was $4.4 million for Q3 2025 at Immucell, down from $4.5 million in the prior quarter.
  • Across five years, Leases topped out at $4.6 million in Q3 2024 and bottomed at $1.1 million in Q2 2022.
  • Average Leases over 5 years is $3.1 million, with a median of $4.2 million recorded in 2023.
  • The sharpest move saw Leases dropped 9.75% in 2022, then soared 307.65% in 2023.
  • Year by year, Leases stood at $1.1 million in 2021, then skyrocketed by 97.87% to $2.2 million in 2022, then surged by 108.28% to $4.6 million in 2023, then decreased by 0.23% to $4.6 million in 2024, then fell by 3.09% to $4.4 million in 2025.
  • Business Quant data shows Leases for ICCC at $4.4 million in Q3 2025, $4.5 million in Q2 2025, and $4.5 million in Q1 2025.